NKTR
USDNektar Therapeutics Common Stock
$9.550-1.848 (-16.213%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$11.398
High
$11.398
Low
$9.310
Volume
0.50M
Company Fundamentals
Market Cap
118.5M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.18M
Exchange
NCM
Currency
USD
52-Week Range
Low $6.45Current $9.550High $22.8
Related News
PR Newswire
Nektar Therapeutics Reports First Quarter 2025 Financial Results
Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2025. Cash and investments in marketable...
View more
PR Newswire
Nektar to Announce Financial Results for the First Quarter on Thursday, May 8, 2025, After Close of U.S.-Based Financial Markets
Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter on Thursday, May 8, 2025, after the close of U.S.-based...
View more
Related Stocks
MMAT
Meta Materials Inc.
NASDAQ
Semiconductors
MHUA
Meihua International Medical Technologies Co. Ltd. Ordinary Shares
NASDAQ
Medical/Dental ...
XENE
Xenon Pharmaceuticals Inc. Common Shares
NASDAQ
Biotechnology: ...
JAMF
Jamf Holding Corp.
NASDAQ
Computer Softwa...
NUV
Nuveen Municipal Value Fund Inc.
NASDAQ
Trusts Except E...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.